The Bombay High Court upheld restrictions on The New Indian Express using the brand name beyond agreed territorial limits under a family settlement. The Court dismissed EPM’s appeal and reaffirmed The Indian Express’s trademark and brand rights.
The Delhi High Court directed Dr Reddy’s Laboratories to stop selling or expanding its diabetes drug “Olymviq,” citing phonetic similarity with Novo Nordisk’s “Ozempic.” Justice Jyoti Singh noted such similarity in pharma crosses an unacceptable threshold, indicating prima facie trademark infringement.
